CCN2 and Alzheimer disease: In contrast to the fluorescence-labeled antibody imaging of CTGF, DGC probe can also easily distinguish CTGF in AD brain sections through POD-catalyzed chromogenic imaging and ICP-MS quantification, respectively (Fig. 7c and Fig. S11).